A Phase 3 Study to Compare Delafloxacin With Moxifloxacin for the Treatment of Adults With Community-Acquired Bacterial Pneumonia (DEFINE-CABP)

BACKGROUND: The clinical and economic burden of community-acquired bacterial pneumonia (CABP) is significant and is anticipated to increase as the population ages and pathogens become more resistant. Delafloxacin is a fluoroquinolone antibiotic approved in the United States for the treatment of adul...

Descripción completa

Detalles Bibliográficos
Autores principales: Horcajada, Juan P, Salata, Robert A, Álvarez-Sala, Rodolfo, Nitu, Floarea Mimi, Lawrence, Laura, Quintas, Megan, Cheng, Chun-Yen, Cammarata, Sue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975251/
https://www.ncbi.nlm.nih.gov/pubmed/31988972
http://dx.doi.org/10.1093/ofid/ofz514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6975251/
https://www.ncbi.nlm.nih.gov/pubmed/31988972
http://dx.doi.org/10.1093/ofid/ofz514

Ejemplares similares